Stockscreener 앱 받기
10.38
2.81%
-0.30
전일 마감가:
$10.68
열려 있는:
$10.8
하루 거래량:
1,957
Relative Volume:
0.12
시가총액:
$6.80M
수익:
-
순이익/손실:
$-19.47M
주가수익비율:
-0.4067
EPS:
-25.5243
순현금흐름:
$-15.57M
1주 성능:
-13.57%
1개월 성능:
-1.42%
6개월 성능:
-56.28%
1년 성능:
-91.69%
1일 변동 폭
$10.38
$10.80
1주일 범위
$9.875
$12.02
52주 변동 폭
$8.67
$196.70
Envveno Medical Corp Stock (NVNO) Company Profile
명칭
Envveno Medical Corp
전화
949-261-2900
주소
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corp
|
10.38 | 6.80M | 0 | -19.47M | -15.57M | -25.52 |
ABT
Abbott Laboratories
|
87.17 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Envveno Medical Corp 주식(NVNO)의 최신 뉴스
enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve - MedTech Intelligence
enVVeno Medical secures FDA IDE approval for venous valve study - Medical Device Network
enVVeno Medical (NVNO) Secures FDA IDE Approval for Pivotal Stud - GuruFocus
enVVeno Medical announces FDA awarded IDE approval to proceed with TAVVEB study - TipRanks
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve - BioSpace
enVVeno Medical Wins FDA IDE for TAVVE Trial - TipRanks
enVVeno receives FDA approval for venous valve pivotal trial By Investing.com - Investing.com South Africa
enVVeno receives FDA approval for venous valve pivotal trial - Investing.com
FDA clears enVVeno (NASDAQ: NVNO) pivotal enVVe CVI valve study - Stock Titan
FDA allows first U.S. study of a nonsurgical vein valve for 3M patients - Stock Titan
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Times Reporter
NVNO enVVeno posts narrower than expected Q3 2025 loss, shares register small gains in today’s trading.CEO Statement - Newser
enVVeno (NVNO) Stock Iron Condor (Breakdown Watch) 2026-04-20Community Sell Signals - Newser
MSN Money - MSN
What is enVVeno Medical Corporations market position2026 Price Swings & AI Driven Stock Movement Reports - baoquankhu1.vn
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - The Florida Times-Union
Stop Loss: What is enVVeno Medical Corporations market positionQuarterly Market Review & Technical Entry and Exit Alerts - baoquankhu1.vn
Whats the profit margin of enVVeno Medical Corporation2026 Market Mood & Risk Managed Investment Signals - baoquankhu1.vn
NVNO PE Ratio & Valuation, Is NVNO Overvalued - Intellectia AI
enVVeno Medical Shares Crash After FDA Reaffirms VenoValve Rejection - MSN
Dow Update: Is enVVeno Medical Corporation a strong candidate for buy and holdMarket Trend Report & Consistent Profit Alerts - baoquankhu1.vn
Market Wrap: Whats the MACD signal for enVVeno Medical Corporation2026 Short Interest & Daily Profit Maximizing Tips - baoquankhu1.vn
enVVeno Medical Corp (NVNO) SEC filings - GuruFocus
enVVeno Medical Corp (NVNO) Stock Earnings Transcripts - GuruFocus
enVVeno Medical Reports FY GAAP EPS of -$33.06 Amid Reverse Stock Split - Intellectia AI
Market Pulse: Whats the MACD signal for enVVeno Medical Corporation2026 Technical Patterns & Weekly Top Gainers Alerts - baoquankhu1.vn
AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO) - TipRanks
enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year - TipRanks
EnVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of EnVVe(R) System - 富途牛牛
No replacement vein valves are approved. enVVeno is pushing one toward a 2026 trial - Stock Titan
[10-K] enVVeno Medical Corp Files Annual Report - Stock Titan
enVVeno Medical 10-K: Net loss $19.5M, no revenue, EPS not disclosed - TradingView
5HJ0 Stock Price and Chart — FWB:5HJ0 - TradingView
If You Invested $1,000 in Envveno Medical Corporation (NVNO) - Stock Titan
NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve - MSN
Insider Sell: Francis Duhay Sells Shares of enVVeno Medical Corp (NVNO) - GuruFocus
[144] enVVeno Medical Corp SEC Filing - Stock Titan
Volatility Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn
enVVeno Medical (NVNO) Stock Analysis Report | Financials & Insights - Benzinga Japan
NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times
Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World
Envveno Medical Corp (NVNO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.93%
자본화:
|
볼륨(24시간):